Overactive Transcription Factor Transforms Normal Epithelial Cells into Tumors
By LabMedica International staff writers Posted on 15 Nov 2010 |
The Sp2 transcription factor, which is overexpressed in many types of human cancer, has been definitively linked to the transformation of epithelial cells into cancer cells in a transgenic mouse model.
Sp proteins are evolutionarily conserved transcription factors required for the expression of a wide variety of genes that are critical for development and cell-cycle progression. Deregulated expression of certain Sp proteins has been shown to be associated with the formation of a variety of human tumors. However, direct evidence linking a specific Sp protein to development of cancer has been lacking.
In the current study, investigators at North Carolina State University (Raleigh, NC, USA) worked with a transgenic mouse model in which animals were either hemizygous or homozygous for the Sp2 gene.
The investigators reported in the November 1, 2010, issue of the journal Cancer Research that overexpression of Sp2 in epidermal basal keratinocytes caused these cells to stop producing differentiated cells and instead to reproduce as undifferentiated (stem cells) cells that eventually progressed to a tumor. Transgenic animals that were homozygous rather than hemizygous for the Sp2 transgene exhibited a striking arrest in the epidermal differentiation program, perishing within two weeks of birth.
"Something happens to normal stem cells that changes the way SP2 is regulated, and it starts being overproduced,” said senior author Dr. Jon Horowitz, associate professor of molecular biomedical sciences at North Carolina State University. "SP2 basically hijacks the stem cell, and turns it into its evil twin – a cancer cell. Our hope is that we can find an "antidote” to SP2, to restore normal cell proliferation to those cancer stem cells and reverse the process.”
Related Links:
North Carolina State University
Sp proteins are evolutionarily conserved transcription factors required for the expression of a wide variety of genes that are critical for development and cell-cycle progression. Deregulated expression of certain Sp proteins has been shown to be associated with the formation of a variety of human tumors. However, direct evidence linking a specific Sp protein to development of cancer has been lacking.
In the current study, investigators at North Carolina State University (Raleigh, NC, USA) worked with a transgenic mouse model in which animals were either hemizygous or homozygous for the Sp2 gene.
The investigators reported in the November 1, 2010, issue of the journal Cancer Research that overexpression of Sp2 in epidermal basal keratinocytes caused these cells to stop producing differentiated cells and instead to reproduce as undifferentiated (stem cells) cells that eventually progressed to a tumor. Transgenic animals that were homozygous rather than hemizygous for the Sp2 transgene exhibited a striking arrest in the epidermal differentiation program, perishing within two weeks of birth.
"Something happens to normal stem cells that changes the way SP2 is regulated, and it starts being overproduced,” said senior author Dr. Jon Horowitz, associate professor of molecular biomedical sciences at North Carolina State University. "SP2 basically hijacks the stem cell, and turns it into its evil twin – a cancer cell. Our hope is that we can find an "antidote” to SP2, to restore normal cell proliferation to those cancer stem cells and reverse the process.”
Related Links:
North Carolina State University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples